Carbamate → N-((3S)-4-(allyloxy)-1-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-yl)-2-(6-(trifluoromethyl)quinazolin-4-ylamino)acetamide
反応式
[F:1][C:2]([F:15])([F:14])[C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][CH:12]=1)[N:9]=[CH:8][NH:7][C:6]2=O.P(Cl)(Cl)(Cl)(Cl)Cl.Cl.Cl.[NH2:24][CH2:25][C:26]([NH2:28])=[O:27].[C:29](N)(=[O:36])[C:30]1[CH:35]=[CH:34][CH:33]=CC=1.FC(F)(F)C1C=[C:42](C=CC=1)[C:43]([NH:45][CH2:46][C:47]([OH:49])=O)=O.C(=O)([O-])N.[CH2:59]1[CH2:69]CN2C(=NCCC2)C[CH2:60]1>ClC(Cl)C.C(#N)C.C1(C)C=CC=CC=1>[CH2:69]([O:49][CH:47]1[CH2:46][N:45]([CH:35]2[CH2:30][CH2:29][O:36][CH2:33][CH2:34]2)[CH2:43][C@@H:42]1[NH:28][C:26](=[O:27])[CH2:25][NH:24][C:6]1[C:5]2[C:10](=[CH:11][CH:12]=[C:3]([C:2]([F:15])([F:14])[F:1])[CH:4]=2)[N:9]=[CH:8][N:7]=1)[CH:59]=[CH2:60]参加物
反応物 7
生成物 1
試薬・触媒・溶媒 3
実験手順
A solution of 6-(trifluoromethyl)quinazolin-4(3H)-one (84 mg, 0.39 mmol, prepared according to WO2005021500A), PCl5 (106 mg, 0.507 mmol) in dichloroethane was sealed in a microwave-safe tube and was microwaved for 3000 seconds reaching an internal temperature of 170° C. An additional portion of PCl5 (25 mg) was added and the mixture was again microwaved for 3000 seconds reaching an internal temperature of 170° C. The mixture was transferred to a flask, toluene was added, then was concentrated. The resulting 4-chloro-6-trifluoromethyl)quinazoline (used without further purification) was dissolved in acetonitrile (2 mL) and was added to a 0° C. cooled mixture of rel-N-[(3R,4R)-4-<allyloxy)-1-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-yl]-2-aminoacetamide-bis-hydrochloride salt (139 mg, 0.309 mmol, prepared in similar fashion to rel-N-(2-{[(3R,4R)-4-(allyloxy)-1-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-yl]amino}-2-oxoethyl)-3-trifluoromethyl)benzamide, substituting [(tert-butoxycarbonyl)amino]acetic acid for {[3-(trifluoromethyl)benzoyl]amino}acetic acid and the resulting tert-butyl rel-(2-{[(3R,4R)-4-allyloxy)-1-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-yl]amino}-2-oxoethyl)carbamate was deprotected under standard HCl/dioxane conditions), DBU (0.292 mL, 1.95 mmol) and acetonitrile (3.5 mL). The mixture was warmed to RT and after 150 min. was quenched with K2CO3 (1M solution) and EtOAc. The organic layer was separated, dried over Na2SO4, filtered and concentrated. The resulting crude product was subjected to flash chromatography (15% MeOH, 1% NH4OH in EtOAc) to afford the title compound (34 mg, 18%) as a white solid. 1H-NMR (DMSO-d6) δ−1.66 (m, 2M), 2.12 (m, 1H), 2.30 (m, 1H), 2.42 (m, 1H), 2.81 (m, 2H), 3.23 (m, 2H), 3.78 (m, 4H), 4.00 (m, 3H), 4.11 (m, 3H), 5.08 (d, 1H), 5.18 (d, 1H), 5.79 (m, 1H), 7.87 (d, 1H), 8.04 (d, 1H), 8.26 (d, 1H), 8.51 (s, 1H), 8.78 (s, 1H), 9.01 (m, 1H). MS m/z=480 (M+1).
後処理
- customwas microwaved for 3000 seconds
- customan internal temperature of 170° C
- customthe mixture was again microwaved for 3000 seconds
- customan internal temperature of 170° C
- customThe mixture was transferred to a flask
- concentrationwas concentrated
- dissolutionThe resulting 4-chloro-6-trifluoromethyl)quinazoline (used without further purification) was dissolved in acetonitrile (2 mL)
- additionwas added to a 0° C.
- temperaturecooled
- customwas quenched with K2CO3 (1M solution) and EtOAc
- customThe organic layer was separated
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
出典と根拠
- ORDレコード
- ord-8972f54274b848b2a2fca84b9213d183
- 出典データセット
- uspto-grants-2011_11
- 特許番号
- US08067457B2
反応ノート
読み込み中…